|1.||Dou, Q Ping: 25 articles (01/2015 - 07/2002)|
|2.||Chen, Di: 12 articles (10/2012 - 01/2004)|
|3.||Cui, Qiuzhi Cindy: 8 articles (01/2011 - 01/2005)|
|4.||Bi, Caifeng: 7 articles (10/2015 - 01/2010)|
|5.||Fan, Yuhua: 7 articles (10/2015 - 01/2010)|
|6.||Kondakova, I V: 7 articles (11/2014 - 01/2012)|
|7.||Yang, Huanjie: 7 articles (08/2010 - 05/2006)|
|8.||Spirina, L V: 6 articles (11/2014 - 01/2012)|
|9.||Kolomiets, L A: 5 articles (11/2014 - 01/2012)|
|10.||Zhang, Xia: 4 articles (01/2015 - 01/2010)|
|1.||Exocrine Pancreatic Insufficiency
08/01/2005 - "To study fecal elastase-1 (E1F) and chymotrypsin (ChT) in stools for the diagnosis of pancreatic insufficiency in pediatric practice. "
10/01/2001 - "The aim of our study was to re-evaluate the sensitivity and specificity of elastase-1 and chymotrypsin in stool in the assessment of exocrine pancreatic insufficiency. "
01/01/1976 - "[Determination of fecal chymotrypsin as a screening test for exocrine pancreatic insufficiency: studies on the reliability of various methods]."
09/01/2004 - "For several years, indirect noninvasive tests of pancreatic insufficiency have been developed, such as fecal chymotrypsin (FChT) and fecal elastase-1 (FEL-1) measurements. "
11/01/1997 - "Pancreatic insufficiency was confirmed by the low level of faecal chymotrypsin found in 85% of cases. "
11/01/1978 - "Point, minute and small cancers of the stomach at the early developmental stage detected by improved chymotrypsin lavage method for diagnostic cytology."
01/01/2014 - "The wide range of chymotrypsin-like activity in tumors was detected. "
01/01/2014 - "Altogether, histology, immunohistochemical expression profile (MUC1+, MUC6+, MUC2-, MUC5AC-, thrypsin-, chymotrypsin-, CDX2-) and sequencing results led to the diagnosis of intraductal tubulopapillary neoplasm. "
10/01/2013 - "Active PSA was detected in tumor frozen sections using PSA750 and this activity was abolished in the presence of the inhibitor, alpha-1 anti-chymotrypsin. "
09/01/1986 - "[Use of chymotrypsin in the surgical treatment of benign tumors and tumor-like diseases of the bones in children]."
04/01/1993 - "We found that although wt viruses grew poorly in cured cells when infection was initiated with intact virions, they grew well in cured cells when infection was initiated with infectious subvirion particles generated from virions by in vitro treatment with chymotrypsin. "
05/01/2013 - "Prior uncoating of virions by chymotrypsin treatment, to generate infectious subviral particles, increased the initial level of infection but without any significant effect on further viral replication or cell survival. "
04/01/2010 - "typhi infection resulted in an increase in gene expression for the chymotrypsin and rab5 that we studied. "
01/01/1992 - "Vaccination with TR-5 which had been activated by chymotrypsin beforehand (active TR-5) elicited protective immunity against otherwise lethal challenge infection with wild-type Sendai virus in DBA/2, C3H and ICR strains of mice. "
01/01/1980 - "Action of chymotrypsin on experimental Plasmodium berghei infection in albino mice."
09/01/1998 - "The efficacy of trypsin: chymotrypsin preparation in the reduction of oxidative damage during burn injury."
11/01/2001 - "Significant differences in cytokine levels (P<0.05) were observed in untreated burn patients and Trypsin-Chymotrypsin preparation treated patients. "
11/01/1997 - "Serum enzymatic changes modulated using trypsin: chymotrypsin preparation during burn wounds in humans."
11/01/2001 - "An increase in serum levels of both cytokines was observed on post burn day 1 and a significant decrease was observed in Trypsin-Chymotrypsin preparation treated patients on days 7 and 10. "
11/01/2001 - "The effects of Trypsin-Chymotrypsin preparation on the modulation of cytokine levels particularly, IL-6 and IL-1beta were analyzed in serum samples of 15 burn patients and compared with untreated controls. "
02/01/2007 - "IC50 values for cytotoxicity against human multiple myeloma cell line RPMI 8226 and inhibition of the chymotrypsin-like (CT-L) activity of purified rabbit 20S proteasomes were determined for all compounds. "
08/01/2014 - "We analysed proteasome concentration and chymotrypsin-like (ChT-L) activity in the plasma of 64 patients with a newly diagnosed multiple myeloma and 30 healthy volunteers. "
08/01/2014 - "Assessment of proteasome concentration and chymotrypsin-like activity in plasma of patients with newly diagnosed multiple myeloma."
02/14/2012 - "The boronic acid dipeptide bortezomib inhibits the chymotrypsin-like activity of the 26S proteasome and shows significant therapeutic efficacy in multiple myeloma. "
10/01/2015 - "In combinations with the clinically approved chymotrypsin-like proteasome inhibitor bortezomib, VR23 produced a synergistic effect in killing multiple myeloma cells, including those that were resistant to bortezomib. "
|2.||Pancreatic Elastase (Elastase)
|3.||Proteasome Endopeptidase Complex (Proteasome)
|5.||Peptide Hydrolases (Proteases)
|6.||Lipase (Acid Lipase)
|2.||Surgical Instruments (Clip)
|4.||Heterologous Transplantation (Xenotransplantation)